Writing and Publishing Scientific Articles
9-6
When Do You Mention Other Studies by Authors’ Names? When you mention someone else’s study in your paper, you have a choice of mentioning the study by the authors’ names ( Jones et al. found ) or by a generic term ( Other researchers found ). As a guideline, use the authors’ names in these 2 situations:
• If the author or study itself is well known in the field.
• If you plan to refer to the study more than once in the paper.
In the paragraph below, the words in bold signal a particular study.
We found that the WW – WW – WW haplotype was the most prevalent haplotype in the lung cancer patients and control subjects but was more common in the control subjects than in the patients. A similar observation has been documented for colorectal cancer and breast cancer. 35,37 The haplotype distribution in this study is similar to that found by Weston et al. , 38 who suggested that rare p53 minor haplotypes are associated with increased risk of breast cancer in some racial groups. Similarly, we found that the rare haplotypes were statistically significantly associated with an elevated risk of lung cancer, with the highest risk found in individuals with the W – M – M alleles. In addition, we found, as did Sjolander et al., 53 that the three loci are in strong linkage disequilibrium. (Wu et al., 2002) Information on attribution signals as well as paraphrasing appears in the chapter “Writing the Discussion Section.”
References for This Chapter
Janus F et al. The dual role for p53 in maintaining genomic integrity. Cell Mol Life Sci 55:12 – 27, 1999.
Wu X et al. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 94:681 – 669, 2002.
All quotations in boxes are from http://www.bob.nap.edu/html/obas/ index.html.
Made with FlippingBook Digital Publishing Software